TRATAMENTO DE ESCLEROSE MÚLTIPLA

• 收藏
• 分享

专利权人:

ORYZON GENOMICS; S.A.

发明人:

TAMARA MAES,CRISTINA MASCARÓ CRUSAT,DAVID ROTLLANT POZO

申请号：

PT17735004

公开号：

PT3307267T

申请日:

2017.06.09

申请国别(地区):

PT

年份:

2019

代理人:

摘要：

The invention relates to biomarkers associated with LSD1 inhibitors and uses thereof to assess target engagement and to follow patient response to treatment. The invention further relates to novel therapeutic uses for LSD1 inhibitors based on said biomarkers.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/